The lysozyme of the microbial source was also proposed for suppressing the growth and/or intestinal colonization of bacterial pathogens in the gastrointestinal tract, and in the treatment of irritable bowel syndrome or inflammatory bowel disease (Crohn’s disease and ulcerative colitis). Here, LYZ is linked to inflammatory bowel disease.